Paracrine effects of transplanted myoblasts and relaxin on post-infarction heart remodelling: In Focus

Journal of Cellular and Molecular Medicine

Volumn 11, Issue 5, 2007, Pages 1087-1100

  Formigli, Lucia ^a   Perna, Avio Maria ^b   Meacci, Elisabetta ^a   Cinci, Lorenzo ^a   Margheri, Martina ^a   Nistri, Silvia ^a   Tani, Alessia ^a   Silvertown, Josh ^c   Orlandini, Giovanni ^a   Porciani, Cristina ^b   Zecchi Orlandini, Sandra ^a   Medin, Jeffrey ^c   Bani, Daniele ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

C2C12 cells; Cell replacement therapy; Infarction; Myoblasts; Myocardial re modelling; Relaxin

Indexed keywords

MATRIX METALLOPROTEINASE; RELAXIN; VASCULOTROPIN A;

ANIMAL; ARTICLE; BLOOD; CELL CULTURE; CELL TRANSPLANTATION; CYTOLOGY; ENZYMOLOGY; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENETICS; HEART INFARCTION; HEART MUSCLE; HEART VENTRICLE REMODELING; MALE; METABOLISM; MOUSE; MYOBLAST; PARACRINE SIGNALING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SWINE; TRANSPLANTATION; ULTRASTRUCTURE;

ANIMALS; CELL TRANSPLANTATION; CELLS, CULTURED; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; MALE; MATRIX METALLOPROTEINASES; MICE; MYOBLASTS; MYOCARDIAL INFARCTION; MYOCARDIUM; PARACRINE COMMUNICATION; RELAXIN; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR REMODELING;

SUIDAE;

EID: 35649009903     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2007.00111.x     Document Type: Article

References (35)

1. Vacanti CA. The history of tissue engineering. J Cell Mol Med. 2006 10 : 569 76.
2. Rubart R, Field LJ. Cardiac regeneration: repopulating the heart. Annu Rev Physiol. 2006 68 : 29 49.
3. Walter DH, Haendeler J, Reinhold J, Rochwalsky U, Seeger F, Honold J, Hoffmann J, Urbich C, Lehmann R, Arenzana-Seisdesdos F, Aicher A, Heeschen C, Fichtlscherer S, Zeiher AM, Dimmeler S. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res. 2005 97 : 1142 51.
4. Ye L, Haider HK, Sim EK. Adult stem cells for cardiac repair: choice between skeletal myoblasts and bone marrow stem cells. Exp Biol Med. 2006 231 : 8 19.
5. Hristov M, Heussen N, Schober A, Weber C. Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocar-dial infarction: a meta-analysis. J Cell Mol Med. 2006 10 : 727 33.
6. Leobon B, Garcin I, Menaschè P, Vilquin J-T, Audinat E, Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA. 2003 100 : 7808 11.
7. Caplice NM. The future of cell therapy for acute myocardial infarction. Nature. 2006 3 : S129 32.
8. Gnecchi M, He H, Noiseux N, Liang OD, Zhan L, Morello F, Mu H, Melo L, Pratt RE, Inwall JS, Dzau VJ. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 2006 20 : 661 9.
9. Berry MF, Engler AJ, Woo YJ, Pirolli TJ, Bish LT, Jayasankar V, Morine KJ, Gardner TJ, Discher DE, Sweeney HL. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol. 2006 290 : H2196 203.
10. Unemori EN, Pickford LB, Salles AL, Piercy CE, Grove BH, Erikson ME, Amento EP. Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vitro. J Clin Invest. 1996 98 : 2739 45.
11. Bani D, Bigazzi M. Clinical aspects and therapeutic perspectives of relaxin. Curr Med Chem-Immunol, Endocr Metab Agents. 2005 5 : 403 10.
12. Conrad KP, Novak J. Emering role of relaxin in renal and cardiovascular function. Am J Physiol Integr Comp Physiol. 2004 287 : R250 61.
13. Perna AM, Masini E, Nistri S, Briganti V, Chiappini L, Stefano P, Bigazzi M, Pieroni C, Bani Sacchi T, Bani D. Novel drug development opportunity for relaxin in acute myocardial infarction: evidences from a swine model. FASEB J. 2005 19 : 1525 7.
14. Wang QD, Sjöquist PO. Myocardial regeneration with stem cells: pharmacological possibilities for efficacy enhancement. Pharmacol Res. 2006 53 : 331 40.
15. Smits PC, van Geuns RJ, Poldermans D, Bountioukos M, Onderwater EE, Lee CH, Maat AP, Serruys PW. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol. 2003 42 : 2063 9.
16. Suzuki K, Murtuza B, Fukushima S, Smolenski RT, Varela-Carver A, Coppen SR, Yacoub MH. Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: distribution, dynamics, and influence on cardiac function. Circulation. 2004 110 : 225 30.
17. Silvertown JD, Ng J, Sato T, Summerlee AJ, Medin JA. H2 relaxin overexpression increases in vivo prostate xenograft tumor growth and angiogenesis. Int J Cancer. 2006 118 : 62 73.
18. Jegger D, Jeanrenaud X, Nasratullah M, Chassot PG, Mallik A, Tevaearai H, von Segesser LK, Segers P, Stergiopulos N. Noninvasive Doppler-derived myocardial performance index in rats with myocardial infarction: validation and correlation by conductance catheter. Am J Physiol Heart Circ Physiol. 2006 290 : H1540 8.
19. Tei C, Ling LH, Hodge DO. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function: a study in normals and dilated cardiomyopathy. J Cardiol. 1995 26 : 357 66.
20. Vandervelde S, van Luyn MJA, Harmsen MC. Signaling factors in stem cell-mediated repair of infarcted myocardium. J Mol Cell Cardiol. 2005 39 : 363 76.
21. Kato M, Dote K, Sasaki S, Goto K, Takemoto H, Habara S, Hasegawa D. Myocardial performance index for assessment of left ventricular outcome in successfully recanalised anterior myocardial infarction. Heart. 2005 91 : 583 8.
22. Uemura R, Xu M, Ahmad N, Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res. 2006 98 : 1414 21.
23. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002 53 : 31 47.
24. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA. 2001 98 : 10344 9.
25. Samuel CS, Du XJ, Bathgate RA, Summers RJ. 'Relaxin' the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular disease. Pharmacol Ther. 2006 112 : 529 52.
26. Hayashidani S, Tsutsui H, Shiomi T, Ikeuki M, Matsusaka H, Suematsu N, Wen J, Eashira K, Takeshita A. Anti-monocyte chemoattractant protein-1 gene tharapy attenuates left ventricular remod-elin and failure after experimental myocardial infarction. Circulation. 2003 108 : 2134 40.
27. Unemori EN, Lewis M, Constant J, Arnold G, Grove BH, Normand J, Deshpande U, Salles A, Pickford LB, Erikson ME, Hunt TK, Huang X. Relaxin induces vascular endothelial growth factor expression and angiogenesis selectively at wound sites. Wound Repair Regen. 2000 8 : 361 70.
28. Hewitson TD, Mookerjee I, Masterson R, Zhao C, Tregear GW, Becker GJ, Samuel CS. Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis. Endocrinology. 2007 148 : 660 9.
29. Vanhoutte D, Schellings M, Pinto Y, Heymans S. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window. Cardiovasc Res. 2006 69 : 604 13.
30. Hughes SM, Blau HM. Migration of myoblasts across basal lamina during skeletal muscle development. Nature. 1990 345 : 350 3.
31. Wainwright CL. Matrix metalloproteinases, oxidative stress and the acute response to acute myocardial ischaemia and reperfusion. Curr Opin Pharmacol. 2004 4 : 132 8.
32. Morita H, Khanal S, Rastogi S, Suzuki G, Imai M, Todor A, Sharov VJ, Goldstein S, Neill TP, Sabbah HN. Selective matrix metalloproinase inhibition attenuates proression of left ventricular dysfunction and remodelling in dogs with chronic heart failure. Am J Physiol Heart Circ Physiol. 2006 290 : H2522 7.
33. Matsumoto R, Omura T, Yoshiyama M, Hayashi T, Inamoto S, Koh KR, Ohta K, Izumi Y, Nakamura Y, Akioka K, Kitaura Y, Takeuchi K, Yoshikawa J. Vascular endothelial growth factor-expression mesnchymal stem cell transplantation for the treatment of acute myocardial infarction. Atheroscler Thromb Vasc Biol. 2005 25 : 1168 73.
34. Wang Y, Haider HK, Ahmad N, Xu M, Ge R, Ashraf M. Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair. J Mol Cell Cardiol. 2006 40 : 736 45.
35. Tang YL, Zhao Q, Qin X, Shen L, Cheng L, Ge J, Phillips MI. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarctium. Ann Thorac Surg. 2005 80 : 229 37.